Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1333493/000133349320000021/ehth2019form10-k.htm
February 2023
February 2023
January 2023
December 2022
November 2022
November 2022
October 2022
August 2022
August 2022
June 2022
• | Revenue for the fourth quarter of 2019 was $301.7 million, a 124% increase compared to $134.9 million for the fourth quarter of 2018. |
• | GAAP net income for the fourth quarter of 2019 was $88.8 million compared to net income of $26.1 million for the fourth quarter of 2018. |
• | Adjusted EBITDA was $142.6 million for the fourth quarter of 2019 compared to $51.9 million for the fourth quarter of 2018. |
• | Fourth quarter 2019 revenue and adjusted EBITDA include the positive impact of $42.3 million in revenue resulting from a change in estimate for expected cash commission collections relating to existing Medicare Advantage plans enrolled in prior to the fourth quarter. |
• | Fourth quarter 2019 approved members for all Medicare products grew 88% compared to the fourth quarter of 2018. |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1333493/000133349320000021/ehth2019form10-k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Ehealth, Inc..
Ehealth, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Rating
Learn More![]()
Additionally, if the plan is the first Medicare Advantage or Medicare Part D prescription drug plan issued to the member, we may receive a higher commission rate that covers a full twelve-month period, regardless of the month the plan was effective.
Adjustments for non-cash items primarily consisted of $12.5 million of stock-based compensation expense, $12.3 million change in fair value of earnout liability, $2.8 million decrease in deferred income taxes, $2.5 million of depreciation and amortization, $2.2 million of amortization of internally-developed software and $2.1 million of amortization of intangible assets.
The growth was primarily due to our strong execution and significant investment in Medicare-related sales and marketing initiatives, which resulted in an 88% growth in Medicare Advantage submitted applications and an 84% growth in Medicare Part D submitted applications.
The improvement in constrained Medicare Advantage plan LTV was driven by increased commission rates and member retention, and the improvement in constrained Medicare Supplement plan LTV was driven by increased commission rates and our acquisition of GoMedigap in January 2018.
The increased number of submitted applications resulted from our strong execution and significant investment in Medicare-related sales and marketing initiatives.
2019 compared to 2018 -...Read more
Since our marketing and advertising...Read more
In the first plan year...Read more
Constrained LTV of commissions per...Read more
We provide annual services in...Read more
Some of our marketing partners...Read more
We estimate commission revenue for...Read more
Adjustments for non-cash items primarily...Read more
Adjustments for non-cash items primarily...Read more
The following table presents our...Read more
IFP CC&E expense per approved...Read more
For our Medicare commission revenue,...Read more
For both Medicare Advantage and...Read more
For all other ancillary health...Read more
The following table presents our...Read more
A contract with a customer...Read more
The following table shows the...Read more
The following table presents summary...Read more
The higher expenses were due...Read more
The increase in operating expenses...Read more
Performance obligations promised in a...Read more
Increases in submitted applications resulting...Read more
Individual and family plan submitted...Read more
Provision (Benefit) for Income Taxes...Read more
The constrained LTV of commissions...Read more
(3) To estimate the number...Read more
Our Individual, Family and Small...Read more
The following table presents a...Read more
Small business approved members grew...Read more
2019 compared to 2018 -...Read more
The increase in operating expenses...Read more
2018 compared to 2017 -...Read more
See Note 1 - Summary...Read more
2019 compared to 2018 -...Read more
The constraints applied to the...Read more
2018 compared to 2017 -...Read more
The decrease in Medicare Part...Read more
The revenue in our Medicare...Read more
Other Income, Net The following...Read more
In addition, in connection with...Read more
(2) To estimate the number...Read more
The following table presents our...Read more
Marketing initiatives are an important...Read more
The following table shows estimated...Read more
Approved members for all ancillary...Read more
To a lesser extent, the...Read more
A portion of our technology...Read more
The estimated average plan duration...Read more
This was driven by 88%...Read more
(2) For small business, the...Read more
Commission revenue increased by $239.5...Read more
The one to three-month period...Read more
2018 compared to 2017 -...Read more
(4) IFP CC&E expense per...Read more
Small business plan estimated membership...Read more
As we continue to evaluate...Read more
The increase was primarily due...Read more
Year Ended December 31, 2018...Read more
2019 compared to 2018 -...Read more
2018 compared 2017 - Technology...Read more
2018 compared to 2017 -...Read more
To the extent we make...Read more
2018 compared 2017 - Marketing...Read more
Investing Activities Our investing activities...Read more
As part of the plan,...Read more
Financing Activities Year Ended December...Read more
Accordingly, we recognize commission revenue...Read more
When provisional amounts are recorded...Read more
Revenue - Medicare segment revenue...Read more
The increase in other Medicare...Read more
The cash decrease resulting from...Read more
Revenue is recognized at the...Read more
The Medicare submitted applications were...Read more
The amendment or termination of...Read more
Individual, Family and Small Business...Read more
We incurred $1.9 million for...Read more
Since tax laws and financial...Read more
The improvement in profit from...Read more
Approved members may not pay...Read more
2018 compared to 2017 -...Read more
The following table shows submitted...Read more
The cash decrease resulting from...Read more
Segment Profit - Our Medicare...Read more
Overview We provide a leading...Read more
In our Medicare business, our...Read more
The increase in Medicare commission...Read more
The increase was primarily due...Read more
The estimated attainment of performance-based...Read more
The increase in Medicare commission...Read more
Small business submitted applications grew...Read more
The increase in revenue from...Read more
Small business estimated membership grew...Read more
2018 compared to 2017 -...Read more
These organizations have relationships with...Read more
Individual, Family and Small Business...Read more
Segment Profit - Our Medicare...Read more
(2) Medicare CC&E expense per...Read more
Our ecommerce technology also enables...Read more
Our estimate of commission revenue...Read more
The increase in personnel costs...Read more
Changes in key assumptions could...Read more
We may also receive commission...Read more
The proceeds of the loans...Read more
Similar to our marketing partner...Read more
Accordingly, we recognize revenue for...Read more
The following table presents our...Read more
While the average plan duration...Read more
The decline in submitted applications...Read more
Additionally, we test goodwill and...Read more
Customer Care and Enrollment Customer...Read more
Our future capital requirements will...Read more
The increase in individual and...Read more
Variable CC&E costs per approved...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Ehealth, Inc. provided additional information to their SEC Filing as exhibits
Ticker: EHTH
CIK: 1333493
Form Type: 10-K Annual Report
Accession Number: 0001333493-20-000021
Submitted to the SEC: Mon Mar 02 2020 12:24:14 PM EST
Accepted by the SEC: Mon Mar 02 2020
Period: Tuesday, December 31, 2019
Industry: Insurance Agents Brokers And Service